Beranda › Pankreatitis › Minnesota
Uji klinis Pankreatitis di Minnesota
7 studi untuk Pankreatitis mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- University of Minnesota/Masonic Children's Hospital, Minneapolis
Menerima pesertaStudi observasional
Hingga usia 17 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06651580DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06899087Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
- Mayo Clinic, Rochester
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06253117Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus
- Mayo Clinic, Rochester
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06729996Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT00830557Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT06401577Diabetes RElated to Acute Pancreatitis and Its Mechanisms
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 18 Nov 2025 · NCT05197920Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.